Back

Hypercontractile phenotype in hypertrophic cardiomyopathy correlate with adverse systemic and coronary parameters

29 August 2025 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy (1) Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Karina Wierzbowska-Drabik

Medical University of Lodz, Lodz (Poland)

3 More presentations in this session

Presentation thumbnail
Incidence and prevalence of hypertrophic cardiomyopathy in Sweden during the years 2003-2022, a nationwide observational study
Doctor J. Silverdal (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Implication of angio-based microvascular resistance for atrial fibrillation in patients with hypertrophic cardiomyopathy
Doctor Y. Pei (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Pharmacogenetics for mavacamten treatment individualization in patients with obstructive hypertrophic cardiomyopathy
Doctor C. Lucas (Marseille, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy (1)

The Event

Event poster

ESC Congress 2025

29 August 2025 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Unfavorable systemic and coronary hemodynamic profile of left ventricular hypercontractile phenotype in hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Hypercontractile phenotype and pharmacological therapy
thumbnail
Congress Session
Imaging to unravel left ventricular hypertrophy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources